An international multicenter experience of biventricular support with HeartMate 3 ventricular assist systems

Jacob Lavee; Johanna Mulzer; Thomas Krabatsch; Silvana Marasco; David McGiffin; Jens Garbade; Jan D. Schmitto; Daniel Zimpfer; Evgenij V. Potapov

doi:10.1016/j.healun.2018.08.008

An international multicenter experience of biventricular support with HeartMate 3 ventricular assist systems

Jacob Lavee
, Johanna Mulzer
, Thomas Krabatsch
, Silvana Marasco
, David McGiffin
, Jens Garbade
, Jan D. Schmitto
, Daniel Zimpfer
, Evgenij V. Potapov

Research output: Contribution to journal › Article › Research › peer-review

78 Citations (Scopus)

Abstract

Significant right ventricular failure accompanying left ventricular failure was treated by implantation of the fully magnetically levitated centrifugal HeartMate 3 ventricular assist device as biventricular (BiVAD) support in 14 patients at 6 medical centers worldwide. The clinical details of this first multicenter experience are presented. Nine of these patients (64%) were alive as of January 1, 2018. Eight of the 9 have continued on BiVAD support for 95 to 636 (mean 266) days: 7 at home, and 1 successfully transplanted after 98 days of support.

Original language	English
Pages (from-to)	1399-1402
Number of pages	4
Journal	Journal of Heart and Lung Transplantation
Volume	37
Issue number	12
DOIs	https://doi.org/10.1016/j.healun.2018.08.008
Publication status	Published - Dec 2018
Externally published	Yes

Keywords

bi-ventricular assist device
bi-ventricular failure
continuous flow ventricular assist device
left ventricular assist device
right ventricular assist device
total artificial heart

Access to Document

10.1016/j.healun.2018.08.008

Cite this

@article{14727ee5b47e42b08d40ffd0e5ee149b,

title = "An international multicenter experience of biventricular support with HeartMate 3 ventricular assist systems",

abstract = "Significant right ventricular failure accompanying left ventricular failure was treated by implantation of the fully magnetically levitated centrifugal HeartMate 3 ventricular assist device as biventricular (BiVAD) support in 14 patients at 6 medical centers worldwide. The clinical details of this first multicenter experience are presented. Nine of these patients (64\%) were alive as of January 1, 2018. Eight of the 9 have continued on BiVAD support for 95 to 636 (mean 266) days: 7 at home, and 1 successfully transplanted after 98 days of support.",

keywords = "bi-ventricular assist device, bi-ventricular failure, continuous flow ventricular assist device, left ventricular assist device, right ventricular assist device, total artificial heart",

author = "Jacob Lavee and Johanna Mulzer and Thomas Krabatsch and Silvana Marasco and David McGiffin and Jens Garbade and Schmitto, \{Jan D.\} and Daniel Zimpfer and Potapov, \{Evgenij V.\}",

year = "2018",

month = dec,

doi = "10.1016/j.healun.2018.08.008",

language = "English",

volume = "37",

pages = "1399--1402",

journal = "Journal of Heart and Lung Transplantation",

issn = "1053-2498",

publisher = "Elsevier",

number = "12",

}

TY - JOUR

T1 - An international multicenter experience of biventricular support with HeartMate 3 ventricular assist systems

AU - Lavee, Jacob

AU - Mulzer, Johanna

AU - Krabatsch, Thomas

AU - Marasco, Silvana

AU - McGiffin, David

AU - Garbade, Jens

AU - Schmitto, Jan D.

AU - Zimpfer, Daniel

AU - Potapov, Evgenij V.

PY - 2018/12

Y1 - 2018/12

N2 - Significant right ventricular failure accompanying left ventricular failure was treated by implantation of the fully magnetically levitated centrifugal HeartMate 3 ventricular assist device as biventricular (BiVAD) support in 14 patients at 6 medical centers worldwide. The clinical details of this first multicenter experience are presented. Nine of these patients (64%) were alive as of January 1, 2018. Eight of the 9 have continued on BiVAD support for 95 to 636 (mean 266) days: 7 at home, and 1 successfully transplanted after 98 days of support.

AB - Significant right ventricular failure accompanying left ventricular failure was treated by implantation of the fully magnetically levitated centrifugal HeartMate 3 ventricular assist device as biventricular (BiVAD) support in 14 patients at 6 medical centers worldwide. The clinical details of this first multicenter experience are presented. Nine of these patients (64%) were alive as of January 1, 2018. Eight of the 9 have continued on BiVAD support for 95 to 636 (mean 266) days: 7 at home, and 1 successfully transplanted after 98 days of support.

KW - bi-ventricular assist device

KW - bi-ventricular failure

KW - continuous flow ventricular assist device

KW - left ventricular assist device

KW - right ventricular assist device

KW - total artificial heart

UR - https://www.scopus.com/pages/publications/85053733484

U2 - 10.1016/j.healun.2018.08.008

DO - 10.1016/j.healun.2018.08.008

M3 - Article

C2 - 30241889

AN - SCOPUS:85053733484

SN - 1053-2498

VL - 37

SP - 1399

EP - 1402

JO - Journal of Heart and Lung Transplantation

JF - Journal of Heart and Lung Transplantation

IS - 12

ER -

An international multicenter experience of biventricular support with HeartMate 3 ventricular assist systems

Abstract

Keywords

Access to Document

Other files and links

Cite this